MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-HR-06-0004457
Qantas Biopharma Private Limited
Qantas Biopharma Private Limited - healthcare in Hisar, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹7.54 Lakh
▲ 36% YoY
Net profit · FY 2024
₹10,432
Net margin 1.4%
EBITDA · FY 2024
₹10,432
EBITDA margin 1.4%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Qantas Biopharma Private Limited
Data last updated:
Qantas Biopharma Private Limited is a private limited company based in Hisar, Haryana, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 17 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U73100HR2020PTC090217. Its GSTIN is 06AAACQ6973H1Z6 (Haryana).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Shakuntla and Ritu.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Shop No.39 Surya Pharma Suraj Market Katla, Hisar, Haryana, India – 125001.
As per the financials filed for FY 2024, the company reported a revenue of ₹7.54 Lakh, a growth of 36% compared to the previous year. For the same year it recorded a net profit of ₹10,432 (net margin 1.4%) and EBITDA of ₹10,432 (EBITDA margin 1.4%). Revenue has grown at a compounded annual rate (CAGR) of 48% over three years.
Qantas Biopharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-06-0004457).
Company details
CIN U73100HR2020PTC090217
Registration Number 090217
Incorporation Date 17 October 2020
ROC Haryana
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-HR-06-0004457
Key People
Shakuntla Director Ritu Director Recognitions & Rankings of Qantas Biopharma
Contact details
Qantas Biopharma Private Limited's registered office is in Hisar, Haryana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No.39 Surya Pharma Suraj Market Katla, Hisar, Haryana, India – 125001
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Qantas Biopharma Private Limited, buy the company report.
Comprehensive company report
Qantas Biopharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Qantas Biopharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Qantas Biopharma Private Limited, buy the company report.
Financials of Qantas Biopharma Private Limited
FY 2024 filings availableQantas Biopharma Private Limited reported revenue of ₹7.54 Lakh (up 36% YoY) for FY 2024.
Revenue · FY 2024
₹7.54 Lakh ▲ 36%
Net profit · FY 2024
₹10,432 margin 1.4%
EBITDA · FY 2024
₹10,432 margin 1.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 36%
3 years · compounded
▲ 48%
EBITDA CAGR growth
1 year
▼ 43%
3 years · compounded
▼ 17%
Revenue has grown at a compounded annual rate (CAGR) of 48% over three years, including 36% growth in the latest year. EBITDA fell 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹10,432 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹10,432 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.4% | |||
| Net Profit Margin | 1.4% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Qantas Biopharma Private Limited, buy the company report.
Peer comparison
Qantas Biopharma Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Biopharma, Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Adreno Pharmaceuticals Private Limited | ₹7.54 Lakh (FY 2025) | -24.0% | Rohini New, Delhi, India | |||
| Qantas Biopharma Private Limitedthis company | ₹7.54 Lakh (FY 2024) | ₹10,432 | 1.4% | 36.0% | Hisar, Haryana, India | |
| Kosido Pharma Private Limited | ₹7.45 Lakh (FY 2025) | 3824.0% | Kolkata, West Bengal, India | |||
| Maya Surgicals Private Limited | ₹7.45 Lakh (FY 2025) | -71.0% | New Delhi, Delhi, India | |||
| Esbhi Enterprises (OPC) Private Limited | ₹7.4 Lakh (FY 2023) | Hyderabad, Telangana, India |
To see the full peer comparison of Qantas Biopharma Private Limited, buy the company report.
Auditor
Qantas Biopharma Private Limited is audited by HIMANSHU MITTAL & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| HIMANSHU MITTAL & CO | FY 2021 | 026169N |
Shareholding
The shareholding of Qantas Biopharma Private Limited is on record for FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Qantas Biopharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Qantas Biopharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Qantas Biopharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Qantas Biopharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAACQ6973H1Z6 | Haryana | Active | 08 Dec 2020 |
To see the full GST registrations and return filing status of Qantas Biopharma Private Limited, buy the company report.
Recent activity
Qantas Biopharma Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Ritu was appointed as Director on 17 Oct 2020.
AGM
Qantas Biopharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Qantas Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Haryana.
Appointed
Ritu was appointed as Director.
Appointed
Shakuntla was appointed as Director.
Incorporation
17 Oct 2020
Qantas Biopharma Private Limited was registered on 17 Oct 2020 with Roc Haryana & aged 6 years 29 days as per MCA records.
Frequently asked questions
Qantas Biopharma is an active private limited company based in Hisar, Haryana, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 17 October 2020 (6+ years old) and is registered under CIN U73100HR2020PTC090217.
The latest financial statements of Qantas Biopharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Qantas Biopharma is 06AAACQ6973H1Z6, registered in Haryana.
The CIN (Corporate Identification Number) of Qantas Biopharma is U73100HR2020PTC090217. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Qantas Biopharma was incorporated on 17 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Qantas Biopharma by revenue are Adreno Pharmaceuticals Private Limited, Kosido Pharma Private Limited, Maya Surgicals Private Limited, Esbhi Enterprises (OPC) Private Limited, all in the Healthcare industry (Biopharma, Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading).
Ritu was appointed as Director on 17 Oct 2020. Shakuntla was appointed as Director on 17 Oct 2020.
Yes, Qantas Biopharma is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-06-0004457).
The registered office of Qantas Biopharma is at Shop No.39 Surya Pharma Suraj Market Katla, Hisar, Haryana, India – 125001.
Qantas Biopharma operates in the healthcare industry, in the medical equipment retail and distribution segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages